Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)

Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)

US Patent 11865111 · Granted Jan 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies and methods for the diagnosis and treatment of Epstein Barr virus inf2025
Prefusion RSV F proteins and their use2025
Heteroaryl inhibitors of PDE42025
Recombinant metapneumovirus f proteins and their use2025
Recombinant HIV-1 envelope proteins and their use2024
Antibodies and methods for the diagnosis, prevention, and treatment of Epstein B2024
Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote2024
Prefusion RSV F proteins and their use2024
Inhibitors for coronavirus2024
Inhibitors for coronavirus2024
Inhibitors for coronavirus2024
Inhibitors for coronavirus2024